This event will be held virtually, as an online webinar. To ensure that you will receive access to the livestream and be kept up to date on any changes to the event, register now. A link to the livestream of the event will be sent to all registrants the day before the event.
Advances in neuroimaging, genetics, and mobile health apps are creating unprecedented opportunities to detect subtle brain changes that may predict the onset of Alzheimer’s disease and other types of dementia. But how much trust should we have in these new technologies, who will have access to them, and how should the law respond when litigants proffer novel evidence of their brain states? This panel will explore technological innovations in dementia detection and their ethical, social, and legal implications.
Brain Health Initiative
Through a groundbreaking collective impact framework that seeks to engage community members in the full research and innovation process – from study design to evaluation – the Brain Health Initiative (BHI) will draw on some of the brightest minds of our time to address what experts say may be the biggest medical priority of the 21st century: brain health.
Featuring collaborative leadership from Massachusetts General Hospital, a Harvard Medical School Teaching Hospital, and the Academy for Brain Health and Performance, the BHI will focus on the science, application, and innovation of brain health promotion, prevention, early identification, evidence-based intervention, and performance optimization across the lifespan.
By 2030, the World Health Organization estimates that half of the worldwide economic impact of disability will be due specifically to brain-related disability. The global toll of brain disorders exceeds that of all other diseases. While brain illness affects one in three individuals, it’s important to remember that brain health is about all of us.
“Genes are not destiny.” – Dr. Stephanie Peabody | PsyD, HSPP, Neuropsychologist | Executive Director